ライフサイエンスコーパス: docosahexaenoic acid

1 rated fatty acids (eicosapentaenoic acid and docosahexaenoic acid).

2 rated acyl chains, including arachidonic and docosahexaenoic acid.

3 yl, 14S-hydroxy-4Z,7Z,9E,11E,13R,14S,16Z,19Z-docosahexaenoic acid.

4 ns D and E, eicosapentaenoic acid (EPA), and docosahexaenoic acid.

5 roduces phosphatidylcholine (PC) enriched in docosahexaenoic acid.

6 ith TLR1 was inhibited by the n-3 fatty acid docosahexaenoic acid.

7 s of PA, oleic acid (OA), linoleic acid, and docosahexaenoic acid.

8 dihydroxydocosapentaenoic acid, derived from docosahexaenoic acid.

9 ed by first covalently linking cysteamine to docosahexaenoic acid.

10 eciprocally higher levels of arachidonic and docosahexaenoic acids.

11 in children who were fed variable amounts of docosahexaenoic acid (0.32%, 0.64%, and 0.96% of total f

12 .58); methionine, 0.31 (95% CI: 0.03, 0.60); docosahexaenoic acid, 0.43 (95% CI: 0.13, 0.73); DMA, 0.

13 ega-3 fatty acids (eicosapentaenoic acid and docosahexaenoic acid; 1 g/d) (n = 370), vitamin D3 and p

14 vel of the Maresin pathway marker 14-hydroxy-docosahexaenoic acid (14-HDHA) was lower in activated pe

15 ipoxygenase (hm12-LOX) gave 14-hydro(peroxy)-docosahexaenoic acid (14-HpDHA), as well as several dihy

16 ations of alpha-linolenic acid (18:3n-3) and docosahexaenoic acid (20:6n-3) increased by 9.4 and 1.9

17 of eicosapentaenoic acid (EPA; 20:5 n-3) and docosahexaenoic acid (22:6 n-3) has been associated with

18 e. eicosapentaenoic acid (20:5 n-3, EPA) and docosahexaenoic acid (22:6 n-3, DHA) has previously prov

19 atty acids: eicosapentaenoic acid (22:5) and docosahexaenoic acid (22:6).

20 ng-chain polyunsaturated fatty acids (PUFAs) docosahexaenoic acid (22:6n-3) and arachidonic acid (20:

21 The proportion of docosahexaenoic acid (22:6n-3) of the total phospholipid

22 ds, eicosapentaenoic acid (20:5n-3, EPA) and docosahexaenoic acid (22:6n-3, DHA).

23 18:3n-3; eicosapentaenoic acid, 20:5n-3; and docosahexaenoic acid, 22:6n-3) comprised primary analyse

24 0 g) and, whilst it contained more (P<0.001) docosahexaenoic acid (30.9 vs. 13.7 mg/100 g), this was

25 ring bioactive cytochrome P450 metabolite of docosahexaenoic acid, a major constituent of fish oil.

26 nhances EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) abundance in the skin, comprehensi

27 The SPM precursor docosahexaenoic acid accelerated resolution via increase

28 xplored.Intakes of eicosapentaenoic acid and docosahexaenoic acid achieved the benchmark of R(2) > 36

29 chemistry, and precursor role of 13,14-epoxy-docosahexaenoic acid, an intermediate in MaR1 biosynthes

30 -glutathionyl, 17-hydroxy-4Z,7Z,10,12,14,19Z-docosahexaenoic acid and 16-cysteinylglycinyl, 17-hydrox

31 a day providing a total daily dose of 800 mg docosahexaenoic acid and 225 mg eicosapentaenoic acid),

32 n total n-3 PUFA, docosapentaenoic acid, and docosahexaenoic acid and 5-y weight change were observed

33 athionyl, 7,17-dihydroxy-4Z,9,11,13Z,15E,19Z-docosahexaenoic acid and 8-cysteinylglycinyl, 7,17-dihyd

34 ssigned to receive formula containing either docosahexaenoic acid and arachidonic acid or no LCPUFAs

35 eceive 1) iron plus placebo, 2) a mixture of docosahexaenoic acid and eicosapentaenoic acid (DHA/EPA)

36 Results obtained with docosahexaenoic acid and eicosapentaenoic acid show ther

37 c, and carotenoids with omega-3 fatty acids (docosahexaenoic acid and eicosapentaenoic acid; group 1,

38 ter-positive GCs and an observed decrease in docosahexaenoic acid and estradiol, also occurring in re

39 ally the (omega)-3 eicosapentaenoic acid and docosahexaenoic acid and micronutrients.

40 tty acids, including the omega-3 fatty acids docosahexaenoic acid and n-3 docosapentaenoic acid.

41 with a human milk fat analogue enriched with docosahexaenoic acid and stearidonic acid, and the antio

42 ated that the bioactive structures contained docosahexaenoic acid and sulfido-conjugate (SC) of trien

43 significant association between the dose of docosahexaenoic acid and the relative risk reduction in

44 mg of lutein, 1 mg of zeaxanthin, 100 mg of docosahexaenoic acid, and 30 mg of eicosapentaenoic acid

45 saturated fatty acids eicosapentaenoic acid, docosahexaenoic acid, and docosapentaenoic acid and vita

46 Levels of arachidic acid, docosahexaenoic acid, and eicosenoic acid were significa

47 LC-PUFAs, particularly docosahexaenoic acid, and nonfried fish, but not shellfi

48 ses including cholesterol, arachidonic acid, docosahexaenoic acid, and triacylglyceride 52:3.

49 apentaenoic acid, docosapentaenoic acid, and docosahexaenoic acid] and alpha-linolenic acid) and n-6

50 minerals, fruit polyphenolics, beta-glucan, docosahexaenoic acid) appropriate for deconstruction and

51 SQ-LNS-plus contained, in addition, docosahexaenoic acid, arachidonic acid (important for br

52 aturated FAs (PUFAs; eicosapentaenoic acid + docosahexaenoic acid, arachidonic acid) in hepatic total

53 T1A8 increased after treatment of cells with docosahexaenoic acid, as did UGT1A protein levels.

54 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid, because of the strength of evidenc

55 ecialized proresolving mediator derived from docosahexaenoic acid, but the mechanism is not known.

56 yl, 14S-hydroxy-4Z,7Z,9E,11E,13R,14S,16Z,19Z-docosahexaenoic acid) by LTC4S and GSTM4.

57 han in the muscle, whereas the proportion of docosahexaenoic acid (C22:6 n-3) was higher in the muscl

58 urated fatty acids eicosapentaenoic acid and docosahexaenoic acid, can exert beneficial effects in in

59 -9 rich), 2) high-oleic acid canola oil with docosahexaenoic acid (CanolaDHA; n-9 and n-3 rich), 3) a

60 tty acids (PUFAs), eicosapentaenoic acid and docosahexaenoic acid, changing significantly over the du

61 onal nutrients, such as the eicosapentaenoic-docosahexaenoic acid combination and percentages of poly

62 Across model systems, docosahexaenoic acid-containing lipids enhance the stabi

63 ixth week of lactation, both arachidonic and docosahexaenoic acids correlated significantly inversely

64 n this study, we investigated the effects of docosahexaenoic acid-derived lipid mediator maresin 1 (M

65 Herein, we found that the docosahexaenoic acid-derived mediator resolvin D3 (RvD3)

66 d 5S-hydroxyeicosatetraenoic acid; decreased docosahexaenoic acid-derived neuroprotectin D1/protectin

67 cid eicosapentaenoic acid-derived resolvins, docosahexaenoic acid-derived resolvins, protectins, and

68 cosapentaenoic acid (DPA) (22:5omega-3), and docosahexaenoic acid (DHA) (22:6omega-3), have been show

69 s of rs174448 tended to associate with lower docosahexaenoic acid (DHA) (P = 0.052).

70 Oral docosahexaenoic acid (DHA) + aspirin therapy has been sh

71 The omega-3-fatty acid, docosahexaenoic acid (DHA) 22:6 n-3, is an important foo

72 show that an acute intravenous injection of docosahexaenoic acid (DHA) 30 min after spinal cord inju

73 Docosahexaenoic acid (DHA) accumulates in the hippocampu

74 saturates, CAL-A was used to concentrate 82% docosahexaenoic acid (DHA) and 11% omega-6 docosapentaen

75 nic acid (ALA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and arachidonic acid (AA) wer

76 The long-chain omega-3 fatty acids (n-3 FAs) docosahexaenoic acid (DHA) and eicosapentaenoic acid (EP

77 Docosahexaenoic acid (DHA) and eicosapentaenoic acid (EP

78 for Thermomyces lanuginosus lipase, so that docosahexaenoic acid (DHA) and eicosapentaenoic acid (EP

79 -3 endocannabinoid epoxides are derived from docosahexaenoic acid (DHA) and eicosapentaenoic acid (EP

80 Maresins are produced by macrophages from docosahexaenoic acid (DHA) and exert potent proresolving

81 acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) and insulin resistance.

82 f hydroxy fatty acids-lipokines derived from docosahexaenoic acid (DHA) and linoleic acid, which were

83 nversion of 18:2n-6 to 20:4n-6 or 18:3n-3 to docosahexaenoic acid (DHA) and little evidence of mammar

84 ntal to nervous system construction, such as docosahexaenoic acid (DHA) and phosphatidylserines, appe

85 D-series resolvins are generated from docosahexaenoic acid (DHA) and promote macrophage-mediat

86 ed by PPL while eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and stearidonic acid (STA) we

87 n intakes of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and the intermediate and adva

88 NIFICANCE STATEMENT Phospholipids containing docosahexaenoic acid (DHA) are greatly enriched in the n

89 Several studies have shown that docosahexaenoic acid (DHA) attenuates epileptic seizures

90 e hypothesis that 600 mg/d of the n-3 LCPUFA docosahexaenoic acid (DHA) can increase maternal and new

91 olving lipid mediators (SPMs) generated from docosahexaenoic acid (DHA) can modulate the vascular inj

92 ic acid (EPA) content remained unchanged and docosahexaenoic acid (DHA) content changed slightly.

93 analyzed for eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) content, as well as for oxida

94 main n-3PUFA eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) could lead to distinct activi

95 omega-3 polyunsaturated fatty acids such as docosahexaenoic acid (DHA) found in oily fish lower bloo

96 ary intake of the natural omega-3 fatty acid docosahexaenoic acid (DHA) has been implicated in protec

97 Docosahexaenoic acid (DHA) has been shown to have signif

98 ng-chain polyunsaturated fatty acid (LCPUFA) docosahexaenoic acid (DHA) has proven effective at reduc

99 ion, and levels of eicosapentaenoic acid and docosahexaenoic acid (DHA) in farmed fish have more than

100 y effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in humans have used a mixture

101 ion, dose of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in omega-3 preparations, and

102 r cells contain the highest concentration of docosahexaenoic acid (DHA) in our bodies, and it has bee

103 d the efficacy of post-TBI administration of docosahexaenoic acid (DHA) in reducing ER stress.

104 s showed that the levels of adrenic acid and docosahexaenoic acid (DHA) in testes were significantly

105 strated that eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) increase systemic concentrati

106 Docosahexaenoic acid (DHA) is a Delta4-desaturated C22 f

107 Docosahexaenoic acid (DHA) is a long-chain polyunsaturat

108 Docosahexaenoic acid (DHA) is a omega-3 fatty acid typic

109 Docosahexaenoic acid (DHA) is an essential omega-3 fatty

110 Docosahexaenoic acid (DHA) is an omega-3 polyunsaturated

111 Docosahexaenoic acid (DHA) is avidly retained in photore

112 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) is currently limited because

113 ption factor PPARgamma by the n-3 fatty acid docosahexaenoic acid (DHA) is implicated in controlling

114 Docosahexaenoic acid (DHA) is important for brain functi

115 Docosahexaenoic acid (DHA) is increasingly considered fo

116 Docosahexaenoic acid (DHA) is uniquely concentrated in t

117 Docosahexaenoic acid (DHA) kinetics appear to change wit

118 d for salivary cortisol, whereas lower serum docosahexaenoic acid (DHA) levels were found in ADHD adu

119 generation indicates that 11-cis-retinal and docosahexaenoic acid (DHA) levels were significantly dec

120 y to restore eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) levels.

121 obese and diabetic rodents is an increase in docosahexaenoic acid (DHA) levels.

122 rcury and the degree to which co-exposure to docosahexaenoic acid (DHA) may obscure these effects in

123 s issue) describe a novel mechanism by which docosahexaenoic acid (DHA) may suppress atopic dermatiti

124 the effect of prenatal supplementation with docosahexaenoic acid (DHA) on birth weight across select

125 llustrates the beneficial effects of dietary docosahexaenoic acid (DHA) on cardiovascular diseases.

126 um-derived factor (PEDF) in combination with docosahexaenoic acid (DHA) on corneal nerve regeneration

127 regnant women supplemented daily with 400 mg docosahexaenoic acid (DHA) or a placebo from 18 to 22 wk

128 re treated with eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) or stearic acid (SA).

129 al-derived factor (PEDF) in combination with docosahexaenoic acid (DHA) or vehicle for 6 weeks, and c

130 We recently found that the end product of docosahexaenoic acid (DHA) oxidation, 2-(omega-carboxyet

131 Docosahexaenoic acid (DHA) plays important physiological

132 ets of pregnant and lactating women [1020 mg docosahexaenoic acid (DHA) plus 180 mg eicosapentaenoic

133 e tested whether 15-18 months treatment with docosahexaenoic acid (DHA) plus eicosapentaenoic acid (E

134 Polyunsaturated fatty acids such as docosahexaenoic acid (DHA) positively affect the outcome

135 igment epithelium-derived factor (PEDF) plus docosahexaenoic acid (DHA) promotes corneal nerve regene

136 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) reduce cardiovascular risk.

137 Long-chain omega-3 fatty acids such as docosahexaenoic acid (DHA) reduce periodontitis in anima

138 upplemental intake of the omega-3 fatty acid docosahexaenoic acid (DHA) reduces risk of Alzheimer's d

139 Infant docosahexaenoic acid (DHA) status is supported by the DH

140 on4 (APOE4) allele are lower responders to a docosahexaenoic acid (DHA) supplement than are noncarrie

141 Eicosapentaenoic acid (EPA) plus docosahexaenoic acid (DHA) supplementation has beneficia

142 Maternal docosahexaenoic acid (DHA) supplementation may prevent b

143 dence have contributed to the rationale that docosahexaenoic acid (DHA) supplementation of preterm in

144 Maternal docosahexaenoic acid (DHA) supplementation prevented the

145 iet intake, and subsequent modification with docosahexaenoic acid (DHA) supplementation.

146 ng PC and PE species, particularly ratios of docosahexaenoic acid (DHA) to arachidonic acid, were low

147 urrent study, we used the endogenous agonist docosahexaenoic acid (DHA) to examine the mechanisms of

148 normal brain function, the pools that supply docosahexaenoic acid (DHA) to the brain are not agreed u

149 Higher maternal docosahexaenoic acid (DHA) was associated with improved

150 noleic acid (LA), arachidonic acid (AA), and docosahexaenoic acid (DHA) was developed using charge-sw

151 % RBC membrane docosahexaenoic acid (DHA) was reduced in FMPD offspring

152 Circulating levels of docosahexaenoic acid (DHA) were also measured.

153 acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA) were inversely correlated wit

154 8-0.98), but eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were not significantly associ

155 ds (n-3 FAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were recommended (at a dose o

156 t sources of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) with 440.2, 343.7 and 313.9 m

157 d (e.g. palmitic acid) and unsaturated (e.g. docosahexaenoic acid (DHA)) LCFAs engage GPR120 and demo

158 ator derived from natural omega-3-fatty acid docosahexaenoic acid (DHA), 10 S,17 S-diHDHA (also refer

159 We show here that the 15-LOX metabolites of docosahexaenoic acid (DHA), 17-hydroperoxy-, 17-hydroxy-

160 Here, we show that docosahexaenoic acid (DHA), a key omega-3 polyunsaturate

161 In vitro studies performed using docosahexaenoic acid (DHA), a model fat molecule, show t

162 Docosahexaenoic acid (DHA), a polyunsaturated omega-3 fa

163 Topical application of docosahexaenoic acid (DHA), a representative omega-3 PUF

164 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), although originally synthesi

165 Here, we show that deficiency in docosahexaenoic acid (DHA), an essential omega-3 fatty a

166 in animals and in humans have suggested that docosahexaenoic acid (DHA), an n-3 long-chain polyunsatu

167 ated the potential benefits of incorporating docosahexaenoic acid (DHA), an omega-3 fatty acid essent

168 , higher plasma eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and total omega-3 (n-3) PUFA

169 he authors is to analyze the serum levels of docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA),

170 polyunsaturated omega-3 fatty acids such as docosahexaenoic acid (DHA), found abundantly in oily fis

171 (PUFAs), particularly the long-chain form of docosahexaenoic acid (DHA), has been linked to health pr

172 igment epithelium-derived factor (PEDF) plus docosahexaenoic acid (DHA), has been shown to stimulate

173 We report that the omega-3 fatty acid docosahexaenoic acid (DHA), in combination with bexarote

174 derived from eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), little is known about the me

175 cids such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), not least of all given the i

176 g linoleic acid (LA), arachidonic acid (AA), docosahexaenoic acid (DHA), or eicosapentaenoic acid (EP

177 -5 fatty acids, alpha-linolenic acid (ALA), docosahexaenoic acid (DHA), rumenic acid (RmA), and alph

178 Docosahexaenoic acid (DHA), supplied by the diet or endo

179 from omega-3 eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), termed resolvins.

180 [dietary fiber, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), vitamin C, and vitamin E] in

181 tors, such as those derived from the omega-3 docosahexaenoic acid (DHA), whose esterified form is tra

182 PRs resulted in a threefold reduction in di-docosahexaenoic acid (DHA)-containing phospholipid speci

183 with select eicosapentaenoic acid (EPA)- and docosahexaenoic acid (DHA)-derived specialized proresolv

184 oic acid (EPA)-enriched n-3 1060 mg day(-1), docosahexaenoic acid (DHA)-enriched n-3 900 mg day(-1) o

185 raceuticals) for fishmeal and whole cells of docosahexaenoic acid (DHA)-rich Schizochytrium sp. as su

186 n polyunsaturated fatty acids, in particular docosahexaenoic acid (DHA).

187 ern diet model in the absence or presence of docosahexaenoic acid (DHA).

188 pigment rhodopsin and the omega-3 fatty acid docosahexaenoic acid (DHA).

189 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

190 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

191 ltransferase (PEMT) pathway is enriched with docosahexaenoic acid (DHA).

192 enoic acid (EPA), docosapentaenoic acid, and docosahexaenoic acid (DHA).

193 were palmitic, oleic and cis-4,7,10,13,16,19-docosahexaenoic acid (DHA).

194 O. tauri is known to efficiently produce docosahexaenoic acid (DHA).

195 is of polyunsaturated fatty acids, including docosahexaenoic acid (DHA).

196 , especially eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

197 mo of 3.9 g eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)/d (4.2 g total omega-3/d; n =

198 uric acid [C12:0], stearic acid [C18:0]) and docosahexaenoic acid (DHA)[C22:6n-3] in order to increas

199 h is rich in eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)] affects insulin sensitivity

200 rated fatty acids [eicosapentaenoic acid and docosahexaenoic acid (DHA)] orchestrate resolution in di

201 being eicosapentaenoic acid (EPA, 6.3%) and docosahexaenoic acid (DHA, 1.6%), both omega-3 FAs.

202 Docosahexaenoic acid (DHA, 22:6 n-3) is abundant in the

203 zzled-related protein (MFRP) participates in docosahexaenoic acid (DHA, 22:6) enrichment in a manner

204 chain n-3 (omega-3) fatty acids (FAs) [e.g., docosahexaenoic acid (DHA, 22:6n-3) and eicosapentaenoic

205 Docosahexaenoic acid (DHA, 22:6n-3) is an essential comp

206 Docosahexaenoic acid (DHA, 22:6n-3) is an omega-3 fatty

207 Docosahexaenoic acid (DHA, 22:6n-3) supplementation in t

208 hain polyunsaturated fatty acids (LC-PUFAs), docosahexaenoic acid (DHA, C22:6) and eicosapentaenoic a

209 The current study showed that docosahexaenoic acid (DHA, C22:6), eicosapentaenoic acid

210 This study investigated the impacts of docosahexaenoic acid (DHA, C22:6, n-3) and/or phosphatid

211 nthocyanidins extract (GSPE) and oil rich in docosahexaenoic acid (DHA-OR) on lipidic postprandial ox

212 nce to support a negative association of low docosahexaenoic acid (DHA; 22:6n-3) with full-scale IQ (

213 via eicosapentaenoic acid (EPA; 20:5n-3) to docosahexaenoic acid (DHA; 22:6n-3), which is required f

214 entrations of EPA (20:5omega-3) (6-fold) and docosahexaenoic acid (DHA; 22:6omega-3) (33%) in relatio

215 eicosapentaenoic acid (EPA; 20:5omega-3) and docosahexaenoic acid (DHA; 22:6omega-3), from diet and s

216 eicosapentaenoic acid (EPA; C20:5(n-3)) and docosahexaenoic acid (DHA; C22:6(n-3)) were noticeable a

217 , such as arachidonic, eicosapentaenoic, and docosahexaenoic acids (DHA), can be acquired from the di

218 containing eicosapentaenoic (EPA, 20:5) and docosahexaenoic acids (DHA, 22:6).

219 ga-3 long-chain polyunsaturated fatty acids (docosahexaenoic acid [DHA] + eicosapentaenoic acid [EPA]

220 Omega-3 fatty acids (docosahexaenoic acid [DHA] and eicosapentaenoic acid [EP

221 80 mg eicosapentaenoic acid [EPA] and 120 mg docosahexaenoic acid [DHA]) daily for 30 days, and the p

222 enoic acid, docosapentaenoic acid [DPA], and docosahexaenoic acid [DHA]) were evaluated with PFTs (FE

223 ay eicosapentaenoic acid [EPA], + 510 mg/day docosahexaenoic acid [DHA]), or fish oil (1000 mg/day EP

224 ay eicosapentaenoic acid [EPA], + 510 mg/day docosahexaenoic acid [DHA]), or fish oil (1000 mg/day EP

225 algae, Schizochytrium sp., is rich source of docosahexaenoic acid, DHA (66%-lipid with 27%-DHA).

226 solving mediators (SPMs) biosynthesized from docosahexaenoic acids (DHAs) including resolvins (Rvs),

227 Docosahexaenoic acid, enriched in the brain and retina,

228 erent n-3 LC-PUFA levels in egg yolk, mainly docosahexaenoic acid enrichment.

229 vanillyl ester (DHA-VE) was synthesized from docosahexaenoic acid ethyl ester (DHA-EE) and vanillyl a

230 daily (840 mg eicosapentaenoic acid/2520 mg docosahexaenoic acid) for 6 months.

231 A (stearic acid) for the sn-1 chain and DHA (docosahexaenoic acid) for the sn-2 chain is representati

232 combined intake of eicosapentaenoic acid and docosahexaenoic acid from diet and supplements was assoc

233 m of eicosapentaenoic, docosapentaenoic, and docosahexaenoic acids) had significantly reduced endomet

234 mega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid have beneficial effects that may le

235 thesized from essential fatty acids, such as docosahexaenoic acid, have tissue protective effects in

236 cid (14-HpDHA), as well as several dihydroxy-docosahexaenoic acids, implicating an epoxide intermedia

237 d the link between fish consumption and high docosahexaenoic acid in breast milk and 2 studies that r

238 fatty acid analysis showed mild decrease in docosahexaenoic acid in the retina of the Rpgr-DKO mice

239 n between 18-carbon TFAs and arachidonic and docosahexaenoic acids in both artery and vein wall lipid

240 R, 17R-trihydroxy-4Z, 9E, 11E, 13Z, 15E, 19Z-docosahexaenoic acid) in reducing ex vivo human SCD bloo

241 Here, we reveal the mechanisms of docosahexaenoic acid-induced phosphorylation of FFA4-L a

242 me P450 epoxygenases from omega-3 fatty acid docosahexaenoic acid, inhibit VEGF- and fibroblast growt

243 that the omega-3 polyunsaturated fatty acid docosahexaenoic acid is robustly incorporated into membr

244 atty acids (0.89; 0.84-0.94; P=6x10(-5)) and docosahexaenoic acid levels (0.90; 0.86-0.95; P=5x10(-5)

245 ue and C-allele carriers exhibited increased docosahexaenoic acid levels.

246 This study determined that hydroxylated docosahexaenoic acid metabolites (HDoHEs) are substrates

247 arachidonic acid, eicosapentaenoic acid, and docosahexaenoic acid metabolomes.

248 id concentrations (eicosapentaenoic acid and docosahexaenoic acid) modify the treatment effect of hom

249 breastmilk components lysozyme (N-S-LYS) or docosahexaenoic acid (N-S-DHA).

250 rage intakes of fish, eicosapentaenoic acid, docosahexaenoic acid, n-3 PUFAs, n-6 PUFAs, and the n-3:

251 ontaining lipid mediators (LMs) derived from docosahexaenoic acid, namely maresin conjugates in tissu

252 plementation with eicosapentaenoic acid plus docosahexaenoic acid (omega-3 polyunsaturated fatty acid

253 e, lutein and zeaxanthin, magnesium, copper, docosahexaenoic acid, omega-3 fatty acid, and alcohol-an

254 ega-3 fatty acids (eicosapentaenoic acid and docosahexaenoic acid) on brain atrophy rates.

255 m of the n-3 PUFAs eicosapentaenoic acid and docosahexaenoic acid (OR, 0.81 [95% CI, 0.66-0.99] for c

256 06), linolenic acid (p < 0.0001, p = 0.002), docosahexaenoic acid (p < 0.0001, p = 0.0024), eicosapen

257 a specialized proresolving mediator from the docosahexaenoic acid pathway shifts the balance toward r

258 relatively innocuous omega-3 fatty acid DHA (docosahexaenoic acid), piracetam, quercetin, vitamin D a

259 More importantly, inhibition of ER stress by docosahexaenoic acid prevented TEV-induced transformatio

260 tin D1/protectin D1 (NPD1/PD1), derived from docosahexaenoic acid, prevents nerve injury-induced mech

261 einylglycinyl, 17-hydroxy-4Z,7Z,10,12,14,19Z-docosahexaenoic acid (Protectin sulfido-conjugates) or 8

262 cid, linoleic acid, alpha-linolenic acid and docosahexaenoic acid PUFAs are associated with AN diagno

263 fatty acids (2 g/day) (eicosapentaenoic acid:docosahexaenoic acid ratio 1:2), vitamin C (1 g/day), an

264 An allosteric Kv1.2 agonist, docosahexaenoic acid, rectifies the dysregulated inhibit

265 glycinyl, 7,17-dihydroxy-4Z,9,11,13Z,15E,19Z-docosahexaenoic acid (Resolvin sulfido-conjugates).

266 s, containing the polyunsaturated fatty acid docosahexaenoic acid, results in the accumulation of an

267 hat proved to be 13-glutathionyl, 14-hydroxy-docosahexaenoic acid (SCI) and 13-cysteinylglycinyl, 14-

268 d (SCI) and 13-cysteinylglycinyl, 14-hydroxy-docosahexaenoic acid (SCII).

269 Docosahexaenoic acid showed a greater inverse associatio

270 Docosahexaenoic acid signaling was one of the top biolog

271 al stability, viscosity, relative content of docosahexaenoic acid, stearidonic acid and total oxidati

272 romal cells exposed to carbon monoxide, with docosahexaenoic acid substrate, produced specialized pro

273 born before 29 weeks of gestation, maternal docosahexaenoic acid supplementation during the neonatal

274 mes more eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid than the fillets of wild fish.

275 Monkeys fed docosahexaenoic acid, the long-chain omega-3 fatty acid

276 olone sulfate, 24(S)-hydroxycholesterol, and docosahexaenoic acid, three endogenous modulators derive

277 t hereditary risk of allergic disease in the Docosahexaenoic Acid to Optimise Mother Infant Outcome r

278 erted 17-hydro(peroxy)-4Z,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid to these bioactive molecules.

279 nses were determined with TG containing only docosahexaenoic acid (Tri-DHA) or eicosapentaenoic acid

280 Arachidonic acid and docosahexaenoic acid, two final products of the enzyme,

281 Docosahexaenoic acid vanillyl ester (DHA-VE) was synthes

282 in an ongoing double-blind treatment trial (docosahexaenoic acid vs placebo; clinicaltrials.gov NCT0

283 Docosahexaenoic acid was converted by platelet 12-lipoxy

284 Finally, docosahexaenoic acid was decreased in calcified tissue c

285 re reduced up to 98%, whereas the content of docosahexaenoic acid was diminished in TG, but not rod c

286 capsules/day, 1080 mg eicosapentaenoic acid+docosahexaenoic acid) was associated with a 33.6% reduct

287 yl, 14S-hydroxy-4Z,7Z,9E,11E,13R,14S,16Z,19Z-docosahexaenoic acid) was catalyzed by gamma-glutamyl tr

288 4S-eMaR (13S,14S-epoxy- 4Z,7Z,9E,11E,16Z,19Z-docosahexaenoic acid) was converted to MCTR1 (13R-glutat

289 e marine omega-3 polyunsaturated fatty acid, docosahexaenoic acid, was associated with 49% higher UL

290 vel of C24:6 n-3, the immediate precursor of docosahexaenoic acid, was decreased in cells expressing

291 sapentanoic acid, docosapentaenoic acid, and docosahexaenoic acid] was 1.18 (95% CI: 1.05, 1.34; P-tr

292 Median changes in eicosapentaenoic acid and docosahexaenoic acid were +87% and +16% for n-3 PUFA ver

293 se blood levels of eicosapentaenoic acid and docosahexaenoic acid were in the lowest third of the tri

294 apentaenoic acid, docosapentaenoic acid, and docosahexaenoic acid were observed.

295 , quartiles 4 versus 1 eicosapentaenoic plus docosahexaenoic acids were suggestively associated with

296 ous anti-inflammatory lipid mediators (e.g., docosahexaenoic acid) were increased in the conditioned

297 apentaenoic acid, docosapentaenoic acid, and docosahexaenoic acid, were associated with a lower child

298 tty acids, such as eicosapentaenoic acid and docosahexaenoic acid, were released more slowly than oth

299 L was dependent upon the FA dose, except for docosahexaenoic acid, which exhibited binding to CD36 bu

300 ved when we examined the association between docosahexaenoic acid, which is one type of LC n-3 PUFA,